EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dorothy Hodgkin lecture 2023: The enteroendocrine system—Sensors in your guts

Frank Reimann

Diabetic Medicine · 2023

DOI: 10.1111/dme.15212 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetic Medicine, 2023. Verfasst von Frank Reimann. Beteiligte Einrichtung: Department of Clinical Biochemistry, Institute of Metabolic Science & MRC Metabolic Diseases Unit, Addenbrooke's Hospital, University of Cambridge, C…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon‐like peptide‐1 (GLP‐1)‐based medication is now widely employed in the treatment of type 2 diabetes and obesity. Like other gut hormones, GLP‐1 is released from eneteroendocrine cells after a meal and in this review, based on the Dorothy Hodgkin lecture delivered during the annual meeting of Diabetes UK in 2023, I argue that there is sufficient spare capacity of GLP‐1 and other gut hormone expressing cells that could be recruited therapeutically. Years of research has revealed several receptors expressed in enteroendocrine cells that could be targeted to stimulate hormone release: although from this research it seems unlikely to find agents that selectively boost GLP‐1, release of a mixture of hormones might be the more desirable outcome anyway, given the recent promising results of new peptides combining GLP1‐receptor with other gut hormone receptor activation. Alternatively, the fact that GLP‐1 and peptideYY (PYY) expressing cells are found in greater density in the ileum might be exploited by increasing the delivery of chyme to the distal small intestine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Gastrointestinal HormonesHumansPeptide YYGlucagon-Like Peptide 1IleumGastric Inhibitory Polypeptide

Stichwörter der Autor:innen

diabetesenteroendocrineglucagon-like peptide-1glucose-dependent insulinotropic polypeptidegut hormoneobesitypeptideYY

Substanzen

Peptide YYGastrointestinal HormonesGlucagon-Like Peptide 1Gastric Inhibitory Polypeptide

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Institute of Metabolic Science & MRC Metabolic Diseases Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council
  • Diabetes UK

Zitieren

APA

Reimann, F. (2023). Dorothy Hodgkin lecture 2023: The enteroendocrine system—Sensors in your guts. Diabetic Medicine. https://doi.org/10.1111/dme.15212

Vancouver

Reimann F. Dorothy Hodgkin lecture 2023: The enteroendocrine system—Sensors in your guts. Diabetic Medicine. 2023. doi:10.1111/dme.15212

BibTeX
@article{Reimann2023,
  author = {Reimann, Frank},
  title = {Dorothy Hodgkin lecture 2023: The enteroendocrine system—Sensors in your guts},
  journal = {Diabetic Medicine},
  year = {2023},
  doi = {10.1111/dme.15212}
}
Kostenlos starten →